Dr. Michael P. Cooreman is a gastroenterologist-hepatologist and Chief Medical Officer at Inventiva; before joining Inventiva in 2020 he was Vice President and Global Therapeutic Area Head Gastroenterology and Hepatology at Ferring. He has held R&D leadership roles at Novartis, Merck, Mitsubishi-Tanabe and biotechnology companies, in R&D related to liver and gastrointestinal diseases, immunology, fibrosis, viral diseases and oncology. Before joining R&D in the biopharmaceutical industry, he worked as a staff hepatologist at the Academic Medical Center of the University of Amsterdam.